| Overview |
| bsm-90174r-50µL |
| cleaved Caspase-9 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Mouse |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human CASP9 |
| 90-350/416 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 842 |
| P55211 |
| CASP9; Caspase 9; ICE-LAP6; APAF-3; MCH6; PPP1R56; Caspase 9 Apoptosis-Related Cysteine Peptidase; Protein Phosphatase 1 Regulatory Subunit 56; ICE-Like Apoptotic Protease 6; Caspase-9; Caspase 9 Apoptosis-Related Cysteine Protease; Apoptotic Protease Activating Factor 3; Apoptotic Protease-Activating Factor 3; Apoptotic Protease MCH-6; Apoptotic Protease Mch-6; EC 3.4.22.62; CASP-9; APAF3 |
| Cell Line: HeLa Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |
Powered by Bioz